Veracyte Announces Fourth Quarter and Full-Year 2023 Financial Results
Grew Fourth Quarter Revenue to $98.2 million Increased 2023 Total Revenue 22% to $361.1 million Conference Call and Webcast Today at 4:30 p.m. ET ...
Source: marketscreener.com
Decipher Biosciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Decipher Biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Decipher Biosciences Today - Breaking & Trending Today
Veracyte Announces Fourth Quarter and Full-Year 2023 Financial Results
Veracyte, Inc. today announced financial results for the fourth quarter and full year ended December 31, 2023. "We closed 2023 with another quarter of excellent results, driven by our Afirma and Decipher businesses," said Marc Stapley, Veracyte's...
Source: lelezard.com
Transforming Cancer Care: Aventa Genomics and the Future of Genomic Testing
In this interview, Chris Roberts of Aventa Genomics highlights the groundbreaking Aventa FusionPlus test, detailing its superior ability to detect gene fusions in cancer diagnostics and its pivotal role in advancing personalized oncology treatments.
Source: news-medical.net
Veracyte Announces Third Quarter 2023 Financial Results
Grew Total Revenue to $90.1 million, an Increase of 19% Grew Testing Revenue by 27% Conference Call and Webcast Today at 4:30 p.m. ET ...
Source: marketscreener.com
Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
SAN DIEGO, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that Tina S. Nova, Ph.D. has been elected as
Source: kentuckytoday.com